Democratising access to genetic services

Familial Cancer
Bryn Williams-Jones, Michael M Burgess

Abstract

Professional and policy discussions about the appropriate funding and allocation of health cares services are an essential part of the management of public and private health care insurance plans. However, the ability of governments and health professionals to equitably decide on the distribution of health care is being challenged by the increasing drive to patent health care technologies. Referring to the case of genetic testing for hereditary breast cancer (and Myriad Genetics' patenting of the BRCA1 & BRCA2 genes), this paper applies some concepts from moral philosophy to think through the effects of the commercialisation of genetic technologies, and what would constitute a more just and rational approach to health care decision-making, in the context of the Canadian health insurance system.

References

Mar 1, 1996·American Journal of Medical Genetics·M M Burgess, M R Hayden
Jul 1, 1997·Nature Medicine·K Birmingham
Apr 29, 1998·BMJ : British Medical Journal·N A Holtzman, D Shapiro
Oct 14, 1998·Health Affairs·N Daniels, J Sabin
Mar 8, 1997·Journal of Health Services Research & Policy·J Lomas
Feb 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Helen A ShihBarbara L Weber
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas S FrankGregory C Critchfield
Apr 16, 2002·The American Journal of Bioethics : AJOB·N Daniels
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Sarah E GollustBenjamin S Wilfond
Nov 22, 2002·Accident and Emergency Nursing·C Jones, M Parsonage
Jul 20, 2005·Journal of Bioethical Inquiry·Michael M Burgess
Feb 23, 2007·New Genetics and Society·Bryn William-Jones

❮ Previous
Next ❯

Citations

Aug 4, 2010·Journal of Genetic Counseling·Alice K Hawkins
Feb 2, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Alice K Hawkins, Michael R Hayden

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.